ID: ALA4105463

Max Phase: Preclinical

Molecular Formula: C17H35NO3

Molecular Weight: 301.47

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCCCCN1C[C@@H](O)[C@H](O)[C@@H](O)C1

Standard InChI:  InChI=1S/C17H35NO3/c1-2-3-4-5-6-7-8-9-10-11-12-18-13-15(19)17(21)16(20)14-18/h15-17,19-21H,2-14H2,1H3/t15-,16+,17+

Standard InChI Key:  SHBOXWUKTOCWMH-FVQHAEBGSA-N

Associated Targets(Human)

Collagen type IV alpha-3-binding protein 18 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 301.47Molecular Weight (Monoisotopic): 301.2617AlogP: 2.31#Rotatable Bonds: 11
Polar Surface Area: 63.93Molecular Species: BASEHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.98CX Basic pKa: 8.51CX LogP: 3.01CX LogD: 1.87
Aromatic Rings: 0Heavy Atoms: 21QED Weighted: 0.51Np Likeness Score: 0.22

References

1. Santos C, Stauffert F, Ballereau S, Dehoux C, Rodriguez F, Bodlenner A, Compain P, Génisson Y..  (2017)  Iminosugar-based ceramide mimicry for the design of new CERT START domain ligands.,  25  (6): [PMID:28237558] [10.1016/j.bmc.2017.02.026]

Source